Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A new agent has been approved for the treatment of the neovascular (wet) form of age-related macular degeneration (AMD).

Ranibizumab Intravitreal Injection (Lucentis™)